Yahoo
NasdaqGS - Nasdaq Real Time Price USD

NRC Health (NRC)

25.86 +0.38 (+1.49%)
At close: November 6 at 4:00:00 PM EST
25.86 0.00 (0.00%)
After hours: November 6 at 4:00:12 PM EST
Trade NRC on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
139,997 137,390 143,060 148,580 151,568
Cost of Revenue
-53,549 -52,371 -56,933 -56,015 -57,049
Gross Profit
86,448 85,019 86,127 92,565 94,519
Selling, General and Administrative Expenses
-63,080 -54,805 -44,911 -46,621 -42,699
Depreciation, Amortization and Depletion
-8,630 -7,624 -6,022 -5,899 -5,277
Operating Income/Expenses
-71,710 -62,429 -50,933 -52,520 -47,976
Total Operating Profit/Loss
14,738 22,590 35,194 40,045 46,543
Total Net Finance Income/Expense
-5,280 -4,650 -2,470 -42 -1,041
Net Investment Income
0 -- 0 0 -2,569
Irregular Income/Expenses
-- -- -- -- 0
Other Income/Expense, Non-Operating
-74 -95 -34 -41 -118
Non-Operating Income/Expenses, Total
-5,354 -4,745 -2,504 -83 -3,728
Pretax Income
9,384 17,845 32,690 39,962 42,815
Provision for Income Tax
-3,525 -6,245 -7,907 -8,991 -11,015
Net Income from Continuing Operations
5,859 11,600 24,783 30,971 31,800
Net Income after Extraordinary Items and Discontinued Operations
5,859 11,600 24,783 30,971 31,800
Net Income after Non-Controlling/Minority Interests
5,859 11,600 24,783 30,971 31,800
Preferred/Other Stock Distribution
-461 -308 -2 -8 -16
Net Income Available to Common Stockholders
5,398 11,292 24,781 30,963 31,784
Diluted Net Income Available to Common Stockholders
5,398 11,292 24,781 30,963 31,784
Common Dividend per Share
0.60 0.52 0.48 1.48 0.84
Basic EPS
0.25 0.50 1.05 1.26 1.28
Diluted EPS
0.25 0.50 1.04 1.25 1.27
Basic Weighted Average Shares Outstanding
21,928.50 22,383 23,703 24,540 24,922
Diluted Weighted Average Shares Outstanding
21,938.50 22,396 23,743 24,673 25,052
Reported Normalized Basic EPS
0.93 0.93 1.05 1.29 --
Reported Normalized Diluted EPS
0.91 0.93 1.05 1.28 --
Income Statement, Supplemental
EBIT
14,664 22,495 35,160 40,004 43,856
EBITDA
23,294 30,084 41,224 45,944 49,136
12/31/2022 - 5/23/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: